$TENX
Tenax Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$1.62
▼-0.01%-$0.000Market closed
Tenax Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is TENX down today? It is at $1.62 (-0.01%), and our scanner flagged it 64 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TENX spikes, and full due diligence on TENX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TENX 64 times in the last 30 days. Create a free account to track $TENX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TENX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TENX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystTENAX THERAPEUTICS, INC.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 12, 2026 · 2 days agoAcross every filing on file, supply equal to 1356.4% of the tradeable float is in play - 1356.4% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $300.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +332K 0.7% of company | added 4.7% | 7.45M | $551K at $1.66 | Oct 21, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +254K 0.6% of company | added 3.7% | 7.12M | $407K at $1.60 | Oct 20, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +337K 0.7% of company | added 5.2% | 6.86M | $508K at $1.51 | Oct 19, 26 |
Doogan Declan Director | Bought (open market) | +53K 0.1% of company | added 100% | 55K | $102K at $1.92 | Sep 16, 26 |
Giordano Christopher Thomas Officer | Bought (open market) | +5K 0.01% of company | added 28% | 22K | $9K at $1.82 | Sep 15, 26 |
Staab Thomas R Ii Officer | Bought (open market) | +6K 0.01% of company | added 57% | 16K | $11K at $1.94 | Sep 11, 26 |
Giordano Christopher Thomas Officer | Bought (open market) | +6K 0.01% of company | added 53% | 17K | $11K at $1.88 | Sep 11, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +900K 2.0% of company | added 16% | 6.52M | $1.6M at $1.78 | Sep 3, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +188K 0.4% of company | added 3.5% | 5.62M | $338K at $1.80 | Sep 2, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +179K 0.4% of company | added 3.4% | 5.44M | $322K at $1.80 | Sep 1, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +404K 0.9% of company | added 8.3% | 5.26M | $722K at $1.79 | Aug 31, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +107K 0.2% of company | added 2.3% | 4.85M | $188K at $1.75 | Aug 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TENX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TENX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TENX last traded at $1.62, down 0.01% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The TENX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TENX 64 times in the last 30 days.
TENX (Tenax Therapeutics, Inc.) trades on XNAS, with a market cap of about $74M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TENX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TENX discussion
Sign in to ask a question or join the discussion.